1Spatial — Trading in line, no COVID-19 impact so far

1Spatial (AIM: SPA)

Last close As at 12/12/2024

GBP0.70

0.00 (0.00%)

Market capitalisation

GBP78m

More on this equity

Research: TMT

1Spatial — Trading in line, no COVID-19 impact so far

1Spatial’s trading update confirms FY20 (ended January) financials will be in line with our estimates. We update exceptionals, amortisation of acquired intangibles and the year-end cash balance but make no material changes to underlying forecasts. The company has seen no impact from COVID-19 so far but is ready to take ‘appropriate action’. Given this, the halving of the share price in the last two weeks seems an overreaction.

Analyst avatar placeholder

Written by

TMT

1Spatial

Trading in line, no COVID-19 impact so far

Trading update

Software & comp services

23 March 2020

Price

13.5p

Market cap

£15m

Net cash (£m) at end FY20

3.9

Shares in issue (pre equity raise)

111m

Free float

93%

Code

SPA

Primary exchange

AIM

Secondary exchange

N/A

Share price performance

%

1m

3m

12m

Abs

(55.0)

(50.9)

(58.5)

Rel (local)

(34.2)

(27.2)

(41.5)

52-week high/low

37.0p

13.5p

Business description

1Spatial’s core technology validates, rectifies and enhances customers’ geospatial data. The combination of its software and advisory services reduces the need for costly manual checking and correcting of data.

Next events

FY results

May 2020

Analysts

Dan Gardiner

+44 (0) 20 3077 5700

Dan Ridsdale

+44 (0) 20 3077 5729

1Spatial is a research client of Edison Investment Research Limited

1Spatial’s trading update confirms FY20 (ended January) financials will be in line with our estimates. We update exceptionals, amortisation of acquired intangibles and the year-end cash balance but make no material changes to underlying forecasts. The company has seen no impact from COVID-19 so far but is ready to take ‘appropriate action’. Given this, the halving of the share price in the last two weeks seems an overreaction.

Year end

Revenue (£m)

Adjusted EBITDA* (£m)

EBIT*
(£m)

EPS*
(p)

EV/sales
(x)

EV/EBIT*
(x)

P/E
(x)

01/18

16.9

0.4

(1.3)

(2.3)

0.7

N/A

N/A

01/19

17.6

1.2

(0.7)

(1.1)

0.6

N/A

N/A

01/20e

23.0

3.1

0.8

0.8

0.5

13.3

17.7

01/21e

25.6

3.7

1.5

1.0

0.4

7.6

13.2

Note: *Adjusted EBITDA, EBIT and EPS (fully diluted) are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. Forecasts include the consolidation of Geomap-Imagis from May 2019.

Revenue/EBITDA at least £23m and £3m

Expectations for revenue and EBITDA of ‘at least’ £23m and £3m are in line with our forecasts. The year-end gross cash balance of £5.1m is below our estimate (£6.1m), reflecting delays in cash collection. We understand collections picked up in February and, excluding a £1.0m exceptional charge related to the Geomap-Imagis (GI) acquisition, 1Spatial generated £1.5m of cash in H2.

Underlying forecasts unchanged despite COVID-19

We adjust our forecasts to include the amortisation of acquired intangibles for the first time (£0.8m, non-cash), increase FY20 exceptionals to £1.0m (previously £0.5m) and reduce our year-end FY20 gross cash balance (see Exhibit 1). However, our underlying forecasts are unchanged. 1Spatial has seen no impact on orders from COVID-19 so far but stands ready to take ‘appropriate action’.

Progress in FY20 and prospects undimmed

1Spatial made substantial progress in FY20 in our view. The GI deal addressed a geography unaligned strategically and underperforming financially (see Fixing France). The business reached underlying EBIT breakeven and was cash generative in H2. Clearly COVID-19 increases forecast uncertainty, but there is no direct impact on 1Spatial so far. The US is growing healthily and the 1Data Gateway launch should significantly enhance scalability.

Valuation: Share price halved, forecasts unchanged

1Spatial’s share price has halved in two weeks. At 13.5p, it stands at its lowest level since listing and the implied FY21e EV/EBIT multiple is just 7.6x. It is difficult to rule out an indirect impact of COVID-19 on the business but 1Spatial appears willing, and has scope, to mitigate an impact should it be needed. In our view, the current rating is not appropriate for a growing, now cash-generative business that has executed well in the last three years.

Forecast changes

Exhibit 1: Forecast changes

£m

FY19

FY20e

FY21e

Old

New

Change (%)

Old

New

Change (%)

Revenue

17.6

22.8

23.0

0.9

25.6

25.6

0.0

EBITDA

1.2

3.1

3.1

0.0

3.7

3.7

0.0

Depreciation

(0.1)

(0.1)

(0.2)

(0.2)

(0.2)

IFRS-16

0.0

(0.0)

(1.0)

(0.0)

(0.9)

Amortisation of cap soft

(1.8)

(2.2)

(1.2)

(2.1)

(1.2)

Adjusted EBIT

(0.7)

0.8

0.8

0.0

1.5

1.5

0.0

Amortisation of acquired intangibles

0.0

0.0

(0.8)

0.0

(1.2)

Exceptionals

(0.7)

(0.5)

(1.0)

0.0

0.0

Reported EBIT

(1.4)

0.3

(1.0)

N/A

1.5

0.3

(78.3)

Gross cash

6.4

6.1

5.1

(16.1)

6.9

6.8

(0.4)

Debt

0.0

(0.8)

(1.2)

(0.8)

(1.2)

Net cash

6.4

5.3

3.9

(26.7)

6.1

5.6

(7.6)

Source: 1Spatial announcements, Edison Investment Research

Exhibit 2: Financial summary

£000s

2016

2017

2018

2019

2020e

2021e

Year end 31 January

IFRS

IFRS

IFRS

IFRS

IFRS

IFRS

PROFIT & LOSS

Revenue

 

 

18,300

15,133

16,938

17,624

23,036

25,638

Delivery costs

(7,715)

(6,868)

(7,994)

(8,449)

(10,953)

(12,325)

Gross Profit

10,585

8,265

8,944

9,175

12,083

13,313

Adjusted EBITDA

 

 

2,902

(874)

403

1,188

3,135

3,730

Operating Profit (before amort. and except.)

 

 

1,584

(12,494)

(1,302)

(738)

836

1,471

Acquired Intangible Amortisation

(200)

0

0

0

(800)

(1,150)

Exceptionals

(1,081)

(2,590)

(1,041)

(672)

(1,000)

0

Share based payments

(976)

(566)

538

(218)

(218)

(218)

Operating Profit

(673)

(15,650)

(1,805)

(1,628)

(1,182)

103

Net Interest

(27)

(25)

(151)

(191)

(36)

(102)

Other

(421)

(266)

0

0

0

0

Profit Before Tax (norm)

 

 

1,136

(12,785)

(1,453)

(929)

799

1,367

Profit Before Tax (FRS 3)

 

 

(1,121)

(15,941)

(1,956)

(1,819)

(1,218)

0

Tax

503

1,081

753

389

150

150

Profit After Tax (norm)

1,136

(12,785)

(1,453)

(929)

799

1,139

Profit After Tax (FRS 3)

(618)

(14,860)

(1,203)

(1,430)

(1,068)

150

Average Number of Shares Outstanding (m)

691.3

728.9

63.3

87.4

104.9

111.2

EPS - normalised (p)

 

 

0.16

(1.75)

(2.30)

(1.06)

0.76

1.02

EPS - normalised fully diluted (p)

 

 

0.16

(1.75)

(2.30)

(1.06)

0.76

1.02

EPS - (IFRS) (p)

 

 

(0.09)

(2.04)

(1.90)

(1.64)

(1.02)

0.14

Dividend per share (p)

0.0

0.0

0.0

0.0

0.0

0.0

Gross Margin (%)

57.8

54.6

52.8

52.1

52.5

51.9

EBITDA Margin (%)

15.9

N/A

2.4

6.7

13.6

14.5

Operating Margin (before GW and except.) (%)

8.7

N/A

N/A

N/A

3.6

5.7

BALANCE SHEET

Fixed Assets

 

 

22,115

13,025

10,873

10,479

13,479

15,279

Intangible Assets

18,900

11,968

10,540

10,194

13,194

14,994

Tangible Assets

1,638

1,057

333

285

285

285

Investments

1,577

0

0

0

0

0

Current Assets

 

 

16,202

11,442

7,050

11,481

16,223

18,371

Stocks

0

0

0

0

0

0

Debtors

10,815

8,929

5,510

4,998

11,000

11,400

Cash

4,996

1,966

1,319

6,358

5,098

6,846

Other

391

547

221

125

125

125

Current Liabilities

 

 

(11,071)

(13,029)

(10,234)

(8,578)

(13,204)

(15,277)

Creditors & other

(11,071)

(12,348)

(9,183)

(8,578)

(12,004)

(14,077)

Short term borrowings

0

(681)

(1,051)

0

(1,200)

(1,200)

Long Term Liabilities

 

 

(1,579)

(1,535)

(899)

(192)

(192)

(192)

Long term borrowings

0

0

0

0

0

0

Other long-term liabilities

(1,579)

(1,535)

(899)

(192)

(192)

(192)

Net Assets

 

 

25,667

9,903

6,790

13,190

16,305

18,181

CASH FLOW

Operating Cash Flow

 

 

(722)

(1,061)

245

(749)

(1,477)

5,300

Net Interest

(31)

(166)

(167)

(175)

(36)

(102)

Tax

55

425

751

410

150

150

Capex

(3,800)

(4,042)

(1,035)

(1,394)

(3,297)

(3,100)

Acquisitions/disposals

(1,033)

(900)

115

0

(4,500)

(500)

Financing

1,940

896

0

7,996

5,500

0

Dividends

0

0

0

0

0

0

Net Cash Flow

(3,342)

(4,848)

(91)

6,088

(2,460)

1,748

Opening net debt/(cash)

 

 

(8,250)

(4,996)

(604)

(268)

(6,358)

(3,898)

HP finance leases initiated

0

0

0

0

0

0

Other

88

456

(245)

2

0

0

Closing net debt/(cash)

 

 

(4,996)

(604)

(268)

(6,358)

(3,898)

(5,646)

Source: Company data, Edison Investment Research. Note: Forecasts include the acquisition of GI from May 2019.

General disclaimer and copyright

This report has been commissioned by 1Spatial and prepared and issued by Edison, in consideration of a fee payable by 1Spatial. Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2020 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

General disclaimer and copyright

This report has been commissioned by 1Spatial and prepared and issued by Edison, in consideration of a fee payable by 1Spatial. Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2020 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on 1Spatial

View All

Latest from the TMT sector

View All TMT content

Research: Healthcare

Hutchison China MediTech — From innovation to oncology commercialisation

Hutchison China MediTech’s (HCM’s) investment case is focused on evolution into a global R&D and commercial-stage biopharma company with a marketed portfolio of innovation-led oncology drugs. 2020 is a golden year as HCM moves towards multiple domestic drug launches and is progressing key assets into registration studies globally. We expect surufatinib (NET) and savolitinib (exon 14 deletion NSCLC) China launches in 2020 and 2021, respectively, following in the footsteps of Elunate (third-line CRC), which is establishing its presence by its inclusion on the National Reimbursement Drug List. HCM is investing in its oncology commercial presence in China and its global clinical and regulatory capabilities (in the US, Europe and Japan). 2022 and 2023 should benefit from global drug launches providing continued pipeline progression. We value HCM at $5.9bn.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free